Found: 5
Select item for more details and to access through your institution.
Genotype-based chemotherapy for patients with gastrointestinal tumors: focus on oxaliplatin, irinotecan, and fluoropyrimidines.
- Published in:
- Drug Metabolism & Personalized Therapy, 2022, v. 37, n. 3, p. 223, doi. 10.1515/dmpt-2021-0162
- By:
- Publication type:
- Article
Pharmacogenetic testing by polymorphic markers G1846A (CYP2D6*4) and C100T (CYP2D6*10) of the CYP2D6 gene in coronary heart disease patients taking ββ-blockers in the Republic of Sakha (YAKUTIA).
- Published in:
- Drug Metabolism & Personalized Therapy, 2018, v. 33, n. 4, p. 195, doi. 10.1515/dmpt-2018-0015
- By:
- Publication type:
- Article
The ABCB1, CYP2C19, CYP3A5 and CYP4F2 genetic polymorphisms and platelet reactivity in the early phases of acute coronary syndromes.
- Published in:
- Drug Metabolism & Personalized Therapy, 2018, v. 33, n. 3, p. 109, doi. 10.1515/dmpt-2018-0006
- By:
- Publication type:
- Article
Pharmacogenetic testing by polymorphic markers 681G>A and 636G>A CYP2C19 gene in patients with acute coronary syndrome and gastric ulcer in the Republic of Sakha (Yakutia).
- Published in:
- Drug Metabolism & Personalized Therapy, 2018, v. 33, n. 2, p. 91, doi. 10.1515/dmpt-2018-0004
- By:
- Publication type:
- Article
MIR27A Gene Polymorphism Modifies the Effect of Common DPYD Gene Variants on Severe Toxicity in Patients with Gastrointestinal Tumors Treated with Fluoropyrimidine-Based Anticancer Therapy.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 15, p. 8503, doi. 10.3390/ijms25158503
- By:
- Publication type:
- Article